Skip to main content

Table 1 Beveled tip, ultra-high speed, 25-gauge pars plana vitrectomy system study data

From: Clinical outcomes of a beveled tip, ultra-high speed, 25-gauge pars plana vitrectomy system

Patient Age (yrs) Gender Diagnosis Surgical steps # Steps Core time (secs) Shave time (secs) PPV time (secs) Total time (secs)
1 29 M VH PPV, LX 2 186 180 366 756
2 69 F MH + ERM PPV, ERM, ILM, LX, FAX, GT 6 372 177 549 2130
3 56 M RRD PPV, FAX, LX, GT 4 474 612 1086 2526
4 62 M RRD PPV, FAX, LX, GT 4 300 708 1008 1956
5 61 F VH PPV, LX 2 240 360 600 1350
6 57 F RRD PPV, FAX, LX, GT 4 120 978 1098 2676
7 64 M MH + ERM PPV, ERM, ILM, FAX, LX, GT 6 270 549 819 3636
8 34 M RRD PPV, FAX, LX, ST 4 246 882 1128 3078
9 38 M VH + ERM PPV, ERM, FAX, LX 4 234 296 530 1506
10 69 M MH PPV, ERM, ILM, FAX, LX, GT, AM 7 474 416 890 3786
11 55 F VH + ERM PE, PPV, ERM, LX, FAX 5 246 302 548 1920
12 74 F DIS + VH PPV, LX, RIOL 3 120 120 240 1686
13 53 F TRD + VH PE, PPV, ERM, LX, FAX, LX 6 594 1782 2376 3726
14 52 M TRD + VH PE, PPV, ERM 3 474 119 593 2250
15 59 M RRD + VH PPV, ERM, FAX, LX 4 180 183 363 810
16 54 M MH, ERM PPV, ERM, FAX, LX 4 120 180 300 1890
17 16 F RRD PPV, ERM, FAX, LX, GT 5 180 400 580 3930
18 63 M VH + ERM PPV, ERM, FAX, LX 4 120 120 240 1230
19 77 F ERM PPV, ERM, LX, FAX 4 180 312 492 1398
20 63 M VH PPV, LX 2 297 408 705 1140
21 84 F VIT PPV, LX 2 238 246 484 798
22 42 M DIS PPV, LX, RIOL, SIOL 4 241 180 421 2118
23 70 M VH + RT PPV, LX, FAX 3 180 234 414 768
24 61 F ERM PPV, ERM, LX, FAX 5 121 120 241 1446
25 69 F ERM PPV, ERM, LX, FAX 4 119 121 239 1026
26 74 M RLF PPV 1 293 120 413 510
27 60 M RRD PPV, FAX, LX, GT 4 120 1188 1308 2640
28 47 F VH, TRD PPV, ERM, ILM, FAX, LX, GT 6 236 426 662 3420
29 84 F MH, ERM PPV, ERM, ILM, FAX, LX, GT 6 60 240 300 2130
30 56 M RRD PPV, PE, PCIOL, ERM, FAX, LX, GT 7 359 546 905 2682
31 34 M TRD + VIT PPV, PE, PCIOL, LX 4 240 300 540 708
32 63 M RRD PPV, FAX, LX, GT 4 240 492 732 1668
33 64 F MH PPV, ERM, LX, FAX 4 120 240 360 2676
34 52 F VIT PPV, MD, FAX 3 301 240 541 1686
35 56 M ERM PPV, ERM, LX, FAX 4 120 120 240 1728
36 59 M DIS PPV, LX, RIOL 3 90 90 180 2010
37 62 F MH PPV, PE, PCIOL, ERM, ILM, FAX, LX, AM, GT 9 105 360 465 2286
38 38 F VH PPV, MD, FAX 3 138 144 282 768
39 51 F MH PPV, ERM, ILM, FAX, LX 5 202 120 322 1116
40 66 F MH PPV, ERM, ILM, FAX, LX, GT 6 150 180 330 2076
41 62 F RRD PPV, FAX, LX, GT 4 83 589 672 2190
42 64 M ERM PPV, ERM, ILM, FAX 4 120 120 240 1308
43 65 M MH PPV, ERM, ILM, FAX, LX 5 72 165 237 1866
44 44 M VH PPV, ERM, LX, FAX 4 90 120 210 918
45 63 F ERM PPV, ERM, ILM, FAX, LX 5 120 120 240 1140
46 38 M RLF PPV, LX 2 60 95 155 1425
47 55 F TRD PPV, PE, PCIOL, ERM, LX, FAX 6 180 150 330 1758
48 62 F MH PPV, ERM, ILM, FAX, LX 5 120 120 240 2250
49 52 M VH PPV, LX, FAX 3 60 120 180 930
50 56 M TRD + VH PPV, PE, PCIOL, LX, ERM, FAX 6 180 120 300 3120
Mean 57.2     4.3 204 330 534 1891
SD 13.5     1.5 120 320 389 890
Patient IOP Day 1 # Times ancillary Instrument placed in eye Objective achieved? Wound leak? Pain score (0–4) Preoperative DCVA Month 3 DCVA logMAR Change Adverse Events Comments
1 4 2 Y N 0 1.854 0.398 −1.456 N  
2 8 8 Y N 0 2.301 1.000 −1.301 N  
3 18 4 Y N 0 2.602 2.301 −0.301 N  
4 10 3 Y N 0 2.602 1.301 −1.301 N  
5 8 2 Y N 0 1.854 0.398 −1.456 N  
6 18 3 Y N 0 2.301 1.301 −1.000 Y Redetachment
7 10 8 Y N 0 2.301 1.000 −1.301 N  
8 6 7 Y N 0 1.854 1.301 −0.553 N  
9 17 5 Y N 0 0.155 0.155 0.000 N  
10 8 7 Y N 0 0.824 0.097 −0.727 Y Nicked retinal blood vessel
11 4 4 Y N 1 0.699 0.699 0.000 N  
12 7 4 Y N 2 0.301 0.301 0.000 N  
13 19 4 Y N 1 1.854 1.301 −0.553 N  
14 10 5 Y N 1 1.854 1.301 −0.553 N  
15 4 3 Y N 0 1.854 0.155 −1.699 N  
16 16 6 Y N 0 0.000 0.000 0.000 N  
17 18 7 Y N 0 2.602 0.699 −1.903 N  
18 12 4 y N 0 1.301 0.301 −1.000 N  
19 0 6 Y N 0 0.301 0.301 0.000 Y Hypotony
20 20 6 Y N 1 1.854 1.000 −0.854 N  
21 4 2 Y N 1 1.854 0.699 −1.155 N  
22 8 3 Y N 0 0.301 0.000 −0.301 N  
23 14 2 Y N 0 2.602 1.000 −1.602 N  
24 9 7 Y N 0 0.301 0.155 −0.146 N  
25 4 4 Y N 0 0.174 0.097 −0.077 N  
26 8 4 Y N 0 0.174 0.000 −0.174 N  
27 4 3 Y N 0 1.301 0.699 −0.602 N  
28 4 5 Y N 0 2.301 1.301 −1.000 Y IOP elevation
29 27 5 Y N 0 0.699 0.824 0.125 N  
30 38 2 Y N 0 0.699 0.398 −0.301 Y IOP elevation
31 5 3 Y N 1 2.301 2.301 0.000 N  
32 4 4 Y N 0 2.301 2.301 0.000 N  
33 0 7 Y N 0 0.699 0.699 0.000 Y Hypotony
34 14 3 Y N 0 1.301 0.523 −0.778 N  
35 18 5 Y N 0 0.174 0.000 −0.174 N  
36 2 8 Y N 1 2.602 2.602 0.000 Y Hypotony
37 15 8 Y N 1 1.854 1.000 −0.854 N  
38 12 1 Y N 0 0.398 0.260 −0.138 N  
39 16 3 Y N 0 0.456 0.222 −0.234 N  
40 8 6 Y N 0 0.398 0.301 −0.097 N  
41 8 4 Y N 0 0.481 0.097 −0.385 N  
42 13 4 Y N 0 1.000 1.000 0.000 N  
43 34 5 Y N 0 1.000 1.000 0.000 Y IOP elevation
44 23 3 Y N 0 0.301 0.155 −0.146 N  
45 10 3 Y N 0 0.301 0.301 0.000 N  
46 16 2 Y N 0 0.155 0.301 0.146 N  
47 8 5 Y N 0 1.854 1.301 −0.553 N  
48 15 7 Y N 0 0.000 0.000 0.000 N  
49 11 2 Y N 0 1.301 0.481 −0.820 N  
50 30 6 Y N 0 1.301 0.301 −1.000 Y IOP elevation
Mean 12.0 4.5     1.237 0.713 −0.524   
SD 8.3 1.9     0.881 0.656 0.562   
  1. Abbreviations: AE Adverse Events, AM Amniotic membrane, DCVA Distance corrected visual acuity, DIS Dislocated Intraocular lens, ERM Epiretinal membrane, FAX Fluid air exchange, GT Gas tamponade, ILM Internal limiting membrane, LX Endolaser photocoagulation, INTRAOP Intraoperative, MD Membrane dissection, MH Macular hole, OR Operative, PPV Pars plana vitrectomy, PREOP Preoperative, RIOL Removal of dislocated IOL, RLF Retained lens fragments, RRD Rhegmatogenous retinal detachment, SIOL Secondary intraocular lens implantation, ST Silicone oil tamponade, TRD Traction retinal detachment, VH Vitreous hemorrhage, VIT Vitritis